4th & Aspen Life Sciences Consulting
•
1 like•1,412 views
4th & Aspen Life Sciences Consulting helps biotech and pharmaceutical companies with drug discovery and development. They have decades of experience in target identification, preclinical research, and commercial assessment. Their team of scientific founders have track records of innovation and leadership at companies like DNAX, Genentech, Neuroscience Inc. 4th & Aspen offers services like opportunity assessment, preclinical evaluation, and commercialization support to help clients manage risk and increase the likelihood of success.
Report
Share
Report
Share
Download to read offline
Recommended
Tsrl fact sheet potent dna therapeutics may 2016
Description of preclinical potent DNA antivirals that are prodrugs of cidofovir for treatment of adenovirus & CMV in immunocompromised populations
Introduction to the TSRL, Inc. Accelerator Model
The document describes TSRL Inc.'s Technology Accelerator program, which aims to help move therapeutic assets past the "Valley of Death" by providing infrastructure, scientific and business resources, and funding to drive projects from pre-clinical development to an Investigational New Drug application. The accelerator selects potential drug candidates based on criteria to maximize commercialization potential and provides services like project management, drug development expertise, and access to networks to help obtain funding and partners. The goal is to generate necessary data packages and commercialization plans to support projects reaching their next development milestones.
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL, Inc. is a preclinical drug development accelerator located in Ann Arbor, Michigan that aims to advance promising compounds for treating severe and drug-resistant infections. The document outlines TSRL's capabilities including analytical testing, pharmacokinetics studies, formulation development, and efficacy modeling. It also discusses funding opportunities through Small Business Innovation Research grants from the National Institute of Allergy and Infectious Diseases as well as other NIH research grants that could support infectious disease drug development.
Tsrl modified dosage forms august_non-confidential
This document discusses a patented formulation technology from TSRL that can modify the release properties of water-insoluble drugs to provide extended or delayed delivery. The technology is supported by an issued US patent that expires in 2033. Proof-of-concept studies in humans have demonstrated the ability to increase exposure and modulate the pharmacokinetic profile of simvastatin using a delayed release formulation. The technology offers a low-cost option for partners to test formulations and has the potential to improve therapies for conditions that follow circadian patterns or require lower and less toxic doses.
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disruptive Innovations Conference
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...Compliance Global Inc
US and EU regulatory requirements for adaptive clinical trials, its rationale, logistics and differences for drug, biologic and medical devicesCardiaX I-Corps@NIH 121014
The team conducted over 100 interviews to validate treating atrial fibrillation using vagus nerve stimulation. Early interviews focused on advanced AF patients but later showed a need to treat early-stage AF patients. The team received funding to develop the approach and acquired a CE marked implantable pulse generator. They completed a feasibility study and are seeking funds for a larger trial to further prove clinical outcomes.
Epigen Biosciences I-Corps@NIH 121014
This document summarizes the progress and findings of Team 12 in developing a drug to treat or prevent chemotherapy-induced peripheral neuropathy (CIPN). Through interviews with 104 people, including physicians, academics, and pharmaceutical companies, the team validated that CIPN is a significant problem with no fully effective treatments. Experts said prophylaxis would be valuable and phase 1 efficacy is possible. The team identified the need for preclinical data on nerve function and relevant cancer types. Pharmaceutical companies indicated interest in preclinical assets for $10M and phase 1 programs for $50-100M. The team plans to submit a grant for preclinical/safety studies and future clinical trials to generate the necessary data.
Recommended
Tsrl fact sheet potent dna therapeutics may 2016
Description of preclinical potent DNA antivirals that are prodrugs of cidofovir for treatment of adenovirus & CMV in immunocompromised populations
Introduction to the TSRL, Inc. Accelerator Model
The document describes TSRL Inc.'s Technology Accelerator program, which aims to help move therapeutic assets past the "Valley of Death" by providing infrastructure, scientific and business resources, and funding to drive projects from pre-clinical development to an Investigational New Drug application. The accelerator selects potential drug candidates based on criteria to maximize commercialization potential and provides services like project management, drug development expertise, and access to networks to help obtain funding and partners. The goal is to generate necessary data packages and commercialization plans to support projects reaching their next development milestones.
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL, Inc. is a preclinical drug development accelerator located in Ann Arbor, Michigan that aims to advance promising compounds for treating severe and drug-resistant infections. The document outlines TSRL's capabilities including analytical testing, pharmacokinetics studies, formulation development, and efficacy modeling. It also discusses funding opportunities through Small Business Innovation Research grants from the National Institute of Allergy and Infectious Diseases as well as other NIH research grants that could support infectious disease drug development.
Tsrl modified dosage forms august_non-confidential
This document discusses a patented formulation technology from TSRL that can modify the release properties of water-insoluble drugs to provide extended or delayed delivery. The technology is supported by an issued US patent that expires in 2033. Proof-of-concept studies in humans have demonstrated the ability to increase exposure and modulate the pharmacokinetic profile of simvastatin using a delayed release formulation. The technology offers a low-cost option for partners to test formulations and has the potential to improve therapies for conditions that follow circadian patterns or require lower and less toxic doses.
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disruptive Innovations Conference
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...Compliance Global Inc
US and EU regulatory requirements for adaptive clinical trials, its rationale, logistics and differences for drug, biologic and medical devicesCardiaX I-Corps@NIH 121014
The team conducted over 100 interviews to validate treating atrial fibrillation using vagus nerve stimulation. Early interviews focused on advanced AF patients but later showed a need to treat early-stage AF patients. The team received funding to develop the approach and acquired a CE marked implantable pulse generator. They completed a feasibility study and are seeking funds for a larger trial to further prove clinical outcomes.
Epigen Biosciences I-Corps@NIH 121014
This document summarizes the progress and findings of Team 12 in developing a drug to treat or prevent chemotherapy-induced peripheral neuropathy (CIPN). Through interviews with 104 people, including physicians, academics, and pharmaceutical companies, the team validated that CIPN is a significant problem with no fully effective treatments. Experts said prophylaxis would be valuable and phase 1 efficacy is possible. The team identified the need for preclinical data on nerve function and relevant cancer types. Pharmaceutical companies indicated interest in preclinical assets for $10M and phase 1 programs for $50-100M. The team plans to submit a grant for preclinical/safety studies and future clinical trials to generate the necessary data.
Magnamosis inc final presentation 12 10
The document outlines the progress of a team developing a magnetic compression device for surgical anastomoses. It includes:
1) The team has developed a device called Magnamosis to create magnetic compression anastomoses and has achieved milestones including animal trials and FDA approval for human trials.
2) Interviews with surgeons found reducing anastomotic leaks to be a key value proposition, as leaks increase costs and morbidity.
3) The team refined their business model based on feedback, deciding to focus early adoption in academic centers and use value-based pricing between $1,200-250 per device.
Nesher Tech I-Corps@NIH 121014
This document summarizes the business model development process of Nesher Technologies Inc., which is developing a single molecule detection technology. Through interviews with over 90 academic researchers, Nesher learned that researchers are interested in software to analyze single molecule data rather than capital equipment. Nesher also explored partnering with microscope and biotech companies but did not find product-market fit. Nesher pivoted to a software-focused business model, developing single molecule analysis software to sell to academic researchers.
CerviCare Columbia
business model, business model canvas, columbia, customer development, lean launchpad, lean startup, steve blank
EH&S Manager
The document describes a job posting for an EH&S Manager - Chemicals position in New Orleans, Louisiana. The EH&S Manager would be responsible for all safety, health, and environmental responsibilities at the facility to ensure compliance with regulations and corporate standards. Key duties include developing and implementing safety and health programs, ensuring regulatory compliance, managing incident investigations and metrics, overseeing budgets, and serving as a technical resource on industrial hygiene and safety issues. The ideal candidate has a bachelor's degree in a safety or health field, 5-10 years of relevant experience, and certifications in industrial hygiene, safety, or eligibility for certifications.
BCN Biosciences I-corps@nih 121014
The document summarizes the findings from 101 interviews conducted by the BCN Biosciences Team over 10 weeks as part of the I-Corps program at NIH to validate the business model for a drug that increases the anti-cancer effect of radiation therapy in lung cancer. Through customer discovery interviews, the team identified fibrosis, specifically lung fibrosis and skin fibrosis, as larger market opportunities than their original focus on radiation mitigation. They evolved their strategy to focus on preventing radiation-induced lung fibrosis, lung fibrosis generally, and using the drug's anti-fibrotic properties for anti-aging applications.
Nicole Russo Resume 2015
Nicole Russo has 8 years of experience managing projects for Colorado Federal Savings Bank. She has a certification in project management from UC Berkeley. As project manager, she oversees 80 employees on various projects related to the bank's strategic goals. Her responsibilities include managing regulatory compliance, budgets, and deliverables. She has experience leading projects involving core banking conversions and new software implementations worth over $1.5 billion.
michael hsu's resume
The applicant is seeking a position as a radiologic technologist. They have over 6 years of experience working in radiology departments performing x-rays, CTs, fluoroscopy, and other imaging exams. They are skilled in all major imaging equipment and software programs. The applicant believes their education and experience in communication, problem solving, and teamwork make them well-qualified for the demanding position.
Kujacznski, Weston - Resume
Weston Kujacznski is seeking an entry-level engineering position. He has a B.S. in chemical engineering and minor in computer science from the University of Michigan. He has research experience developing computational models of nanoparticles and automating processes. He also has international work experience in product development at a Chinese biomedical company where he helped strengthen their FDA application. Kujacznski has skills in process engineering, problem solving, quality control, and programming languages.
Gammaglobulin I-Corps@NIH 121014
The document discusses developing a recombinant gammaglobulin product as an alternative to plasma-derived intravenous immunoglobulin (IVIG) treatments. It summarizes interviews with potential customers to understand their needs and determine the value proposition. Key stakeholders are identified as patients, healthcare providers, and regulators. Partners discussed include contract manufacturing organizations, clinical trial sites, and specialty pharmacies for distribution.
Advance Health Stanford 2016
agile, business model, corporate innovation, customer development, lean, lean startup, lean launchpad, stanford, steve blank, video, engr 245
Jill Woods Resume 20150401
Jill Woods has over 20 years of experience in quality assurance roles within the pharmaceutical, biotechnology, and medical device industries. She has managed quality assurance systems, conducted inspections, ensured regulatory compliance, and responded to customer complaints and investigations. Woods has experience hosting domestic and international regulatory inspections.
DSA_Infographic_Final
The document discusses the complex regulatory landscape of pharmacovigilance and how DSA ensures a smooth journey for clients to focus on other crucial areas of product development. It lists several regulatory changes between 2012-2015 from agencies like EMA, FDA, and ICH. DSA provides compliance, regulation, and implementation solutions including a pharmacovigilance database hosted on Oracle platforms in a tier 3 data center. DSA employees are tenured life science or healthcare professionals with experience across therapeutic areas, products, and supporting over 11 global regulatory inspections.
Cellscan Stanford 2016
agile, business model, corporate innovation, customer development, lean, lean startup, lean launchpad, stanford, steve blank, video, engr 245
Nest sense berkeley 2015
The document summarizes the findings from an investigation into developing a smart home monitoring system to help families care for loved ones with dementia. Over 12 weeks, the team conducted interviews and built prototypes to understand customer needs. They initially focused on too many use cases, but learned safety monitoring was key. The team identified the target customer as adult children caring for mildly moderate stage parents from a distance. Moving forward, the team plans pilot studies and partnerships to validate the product and business model.
ODC Pharma
ODC Pharma is a staffing and recruiting firm that partners with pharmaceutical, CRO, biotech, and medical device organizations globally to help them attain excellence in their talent strategies. They provide temporary staffing, temp-to-perm placements, direct hire/permanent staffing, executive level staffing, and outsourcing/specialized staffing services. Some of the clinical and scientific positions they recruit for include clinical research associates, clinical data managers, SAS programmers, regulatory affairs specialists, biostatisticians, lab technicians, toxicologists, and more.
Resume Kent Ferguson
Kent Ferguson has over 15 years of experience in manufacturing, quality, and supply chain engineering roles. He is currently a Manufacturing Engineer at AFA Zone 1 managing a $1.5 million project replacing vision systems. Previously, he held positions at Gore Medical driving strategic sourcing decisions, identifying inefficiencies to improve forecasting and equipment utilization, and achieving 100% recruiting acceptance. Ferguson has an MBA in Supply Chain Management from BYU and a BS in Manufacturing Engineering Technology, also from BYU. He has extensive training in Lean, Six Sigma and skills in data analysis software.
ODC Pharma Capabilities
The document provides an overview of ODC Pharma's staffing capabilities and core competencies. ODC Pharma's mission is to exceed customer expectations in the pharmaceutical, biotechnology, and medical device industries by delivering exemplary staffing services. They have experience filling various clinical, scientific, and executive level positions. ODC Pharma is headquartered in Cherry Hill, NJ with additional offices in Durham, NC and San Diego, CA.
Guadalupe Bend Consulting LLC
Jay McElhenney is the owner and principal consultant of Guadalupe Bend Consulting LLC. He has over 30 years of experience in the medical device field, primarily in manufacturing operations, new product commercialization, quality engineering, and quality systems. His expertise includes full quality system implementation, quality engineering, contract manufacturing and supply chain management, new product commercialization, business development, and supporting start-ups. Guadalupe Bend Consulting provides consulting services to medical device companies in operations, quality, and new product commercialization.
Raghav_CDM-Exp_4.5yrs
This document provides a summary of Raghavendra S's career and qualifications. It outlines his 4 years of experience in clinical data management, knowledge of FDA and CDISC guidelines, and experience handling clinical trial data from various sources. It also lists his educational background, including an MSc in Applied Genetics and BSc in Biotechnology. Raghavendra has worked for several companies, including PPD and Quintiles, managing clinical trials and databases in therapeutic areas such as oncology, cardiology, and psychiatry.
Preventing Off-label Sales Promotion
This document discusses preventing off-label sales promotion and the associated risks. It notes that as regulatory enforcement increases, off-label sales activities can lead to criminal prosecutions, investigations into company records, and hurt companies in product liability lawsuits. The document provides seven insights for preventing off-label promotion, including hiring employees with integrity, providing ongoing off-label education, making compliance messaging easier than off-label messaging, and establishing a cross-functional team to review off-label requests from physicians. Real-life best practices are also suggested, such as sales managers educating representatives on approved vs. off-label uses when preparing for meetings.
Vedic Lifesciences Pvt Ltd
Vedic Lifesciences is a contract research organization founded in 2000 that provides drug development services to pharmaceutical companies. It has managed over 34 clinical trials and 248 preclinical studies across multiple therapeutic areas. Services include regulatory submissions, clinical project management, data management, biostatistics, and medical writing. Vedic has experience in areas such as oncology, diabetes, orthopedics, andrology, and inflammation. It employs a team of experts including clinical researchers, medical writers, and regulatory specialists to support its clients.
Vedic Lifesciences Pvt Ltd.
Vedic Lifesciences is a contract research organization founded in 2000 that provides drug development services to pharmaceutical companies. It has managed over 34 clinical trials and 248 preclinical studies across multiple therapeutic areas. Services include regulatory submissions, clinical project management, data management, biostatistics, and medical writing. Vedic has experience in areas such as oncology, diabetes, orthopedics, andrology, and inflammation. It employs a team of experts including clinical researchers, medical writers, and regulatory specialists to support its clients.
More Related Content
What's hot
Magnamosis inc final presentation 12 10
The document outlines the progress of a team developing a magnetic compression device for surgical anastomoses. It includes:
1) The team has developed a device called Magnamosis to create magnetic compression anastomoses and has achieved milestones including animal trials and FDA approval for human trials.
2) Interviews with surgeons found reducing anastomotic leaks to be a key value proposition, as leaks increase costs and morbidity.
3) The team refined their business model based on feedback, deciding to focus early adoption in academic centers and use value-based pricing between $1,200-250 per device.
Nesher Tech I-Corps@NIH 121014
This document summarizes the business model development process of Nesher Technologies Inc., which is developing a single molecule detection technology. Through interviews with over 90 academic researchers, Nesher learned that researchers are interested in software to analyze single molecule data rather than capital equipment. Nesher also explored partnering with microscope and biotech companies but did not find product-market fit. Nesher pivoted to a software-focused business model, developing single molecule analysis software to sell to academic researchers.
CerviCare Columbia
business model, business model canvas, columbia, customer development, lean launchpad, lean startup, steve blank
EH&S Manager
The document describes a job posting for an EH&S Manager - Chemicals position in New Orleans, Louisiana. The EH&S Manager would be responsible for all safety, health, and environmental responsibilities at the facility to ensure compliance with regulations and corporate standards. Key duties include developing and implementing safety and health programs, ensuring regulatory compliance, managing incident investigations and metrics, overseeing budgets, and serving as a technical resource on industrial hygiene and safety issues. The ideal candidate has a bachelor's degree in a safety or health field, 5-10 years of relevant experience, and certifications in industrial hygiene, safety, or eligibility for certifications.
BCN Biosciences I-corps@nih 121014
The document summarizes the findings from 101 interviews conducted by the BCN Biosciences Team over 10 weeks as part of the I-Corps program at NIH to validate the business model for a drug that increases the anti-cancer effect of radiation therapy in lung cancer. Through customer discovery interviews, the team identified fibrosis, specifically lung fibrosis and skin fibrosis, as larger market opportunities than their original focus on radiation mitigation. They evolved their strategy to focus on preventing radiation-induced lung fibrosis, lung fibrosis generally, and using the drug's anti-fibrotic properties for anti-aging applications.
Nicole Russo Resume 2015
Nicole Russo has 8 years of experience managing projects for Colorado Federal Savings Bank. She has a certification in project management from UC Berkeley. As project manager, she oversees 80 employees on various projects related to the bank's strategic goals. Her responsibilities include managing regulatory compliance, budgets, and deliverables. She has experience leading projects involving core banking conversions and new software implementations worth over $1.5 billion.
michael hsu's resume
The applicant is seeking a position as a radiologic technologist. They have over 6 years of experience working in radiology departments performing x-rays, CTs, fluoroscopy, and other imaging exams. They are skilled in all major imaging equipment and software programs. The applicant believes their education and experience in communication, problem solving, and teamwork make them well-qualified for the demanding position.
Kujacznski, Weston - Resume
Weston Kujacznski is seeking an entry-level engineering position. He has a B.S. in chemical engineering and minor in computer science from the University of Michigan. He has research experience developing computational models of nanoparticles and automating processes. He also has international work experience in product development at a Chinese biomedical company where he helped strengthen their FDA application. Kujacznski has skills in process engineering, problem solving, quality control, and programming languages.
Gammaglobulin I-Corps@NIH 121014
The document discusses developing a recombinant gammaglobulin product as an alternative to plasma-derived intravenous immunoglobulin (IVIG) treatments. It summarizes interviews with potential customers to understand their needs and determine the value proposition. Key stakeholders are identified as patients, healthcare providers, and regulators. Partners discussed include contract manufacturing organizations, clinical trial sites, and specialty pharmacies for distribution.
Advance Health Stanford 2016
agile, business model, corporate innovation, customer development, lean, lean startup, lean launchpad, stanford, steve blank, video, engr 245
Jill Woods Resume 20150401
Jill Woods has over 20 years of experience in quality assurance roles within the pharmaceutical, biotechnology, and medical device industries. She has managed quality assurance systems, conducted inspections, ensured regulatory compliance, and responded to customer complaints and investigations. Woods has experience hosting domestic and international regulatory inspections.
DSA_Infographic_Final
The document discusses the complex regulatory landscape of pharmacovigilance and how DSA ensures a smooth journey for clients to focus on other crucial areas of product development. It lists several regulatory changes between 2012-2015 from agencies like EMA, FDA, and ICH. DSA provides compliance, regulation, and implementation solutions including a pharmacovigilance database hosted on Oracle platforms in a tier 3 data center. DSA employees are tenured life science or healthcare professionals with experience across therapeutic areas, products, and supporting over 11 global regulatory inspections.
Cellscan Stanford 2016
agile, business model, corporate innovation, customer development, lean, lean startup, lean launchpad, stanford, steve blank, video, engr 245
Nest sense berkeley 2015
The document summarizes the findings from an investigation into developing a smart home monitoring system to help families care for loved ones with dementia. Over 12 weeks, the team conducted interviews and built prototypes to understand customer needs. They initially focused on too many use cases, but learned safety monitoring was key. The team identified the target customer as adult children caring for mildly moderate stage parents from a distance. Moving forward, the team plans pilot studies and partnerships to validate the product and business model.
ODC Pharma
ODC Pharma is a staffing and recruiting firm that partners with pharmaceutical, CRO, biotech, and medical device organizations globally to help them attain excellence in their talent strategies. They provide temporary staffing, temp-to-perm placements, direct hire/permanent staffing, executive level staffing, and outsourcing/specialized staffing services. Some of the clinical and scientific positions they recruit for include clinical research associates, clinical data managers, SAS programmers, regulatory affairs specialists, biostatisticians, lab technicians, toxicologists, and more.
Resume Kent Ferguson
Kent Ferguson has over 15 years of experience in manufacturing, quality, and supply chain engineering roles. He is currently a Manufacturing Engineer at AFA Zone 1 managing a $1.5 million project replacing vision systems. Previously, he held positions at Gore Medical driving strategic sourcing decisions, identifying inefficiencies to improve forecasting and equipment utilization, and achieving 100% recruiting acceptance. Ferguson has an MBA in Supply Chain Management from BYU and a BS in Manufacturing Engineering Technology, also from BYU. He has extensive training in Lean, Six Sigma and skills in data analysis software.
ODC Pharma Capabilities
The document provides an overview of ODC Pharma's staffing capabilities and core competencies. ODC Pharma's mission is to exceed customer expectations in the pharmaceutical, biotechnology, and medical device industries by delivering exemplary staffing services. They have experience filling various clinical, scientific, and executive level positions. ODC Pharma is headquartered in Cherry Hill, NJ with additional offices in Durham, NC and San Diego, CA.
Guadalupe Bend Consulting LLC
Jay McElhenney is the owner and principal consultant of Guadalupe Bend Consulting LLC. He has over 30 years of experience in the medical device field, primarily in manufacturing operations, new product commercialization, quality engineering, and quality systems. His expertise includes full quality system implementation, quality engineering, contract manufacturing and supply chain management, new product commercialization, business development, and supporting start-ups. Guadalupe Bend Consulting provides consulting services to medical device companies in operations, quality, and new product commercialization.
Raghav_CDM-Exp_4.5yrs
This document provides a summary of Raghavendra S's career and qualifications. It outlines his 4 years of experience in clinical data management, knowledge of FDA and CDISC guidelines, and experience handling clinical trial data from various sources. It also lists his educational background, including an MSc in Applied Genetics and BSc in Biotechnology. Raghavendra has worked for several companies, including PPD and Quintiles, managing clinical trials and databases in therapeutic areas such as oncology, cardiology, and psychiatry.
Preventing Off-label Sales Promotion
This document discusses preventing off-label sales promotion and the associated risks. It notes that as regulatory enforcement increases, off-label sales activities can lead to criminal prosecutions, investigations into company records, and hurt companies in product liability lawsuits. The document provides seven insights for preventing off-label promotion, including hiring employees with integrity, providing ongoing off-label education, making compliance messaging easier than off-label messaging, and establishing a cross-functional team to review off-label requests from physicians. Real-life best practices are also suggested, such as sales managers educating representatives on approved vs. off-label uses when preparing for meetings.
What's hot (20)
Similar to 4th & Aspen Life Sciences Consulting
Vedic Lifesciences Pvt Ltd
Vedic Lifesciences is a contract research organization founded in 2000 that provides drug development services to pharmaceutical companies. It has managed over 34 clinical trials and 248 preclinical studies across multiple therapeutic areas. Services include regulatory submissions, clinical project management, data management, biostatistics, and medical writing. Vedic has experience in areas such as oncology, diabetes, orthopedics, andrology, and inflammation. It employs a team of experts including clinical researchers, medical writers, and regulatory specialists to support its clients.
Vedic Lifesciences Pvt Ltd.
Vedic Lifesciences is a contract research organization founded in 2000 that provides drug development services to pharmaceutical companies. It has managed over 34 clinical trials and 248 preclinical studies across multiple therapeutic areas. Services include regulatory submissions, clinical project management, data management, biostatistics, and medical writing. Vedic has experience in areas such as oncology, diabetes, orthopedics, andrology, and inflammation. It employs a team of experts including clinical researchers, medical writers, and regulatory specialists to support its clients.
BVAS2015J
Bay View Advisory Services is a subsidiary of Bay View Clinic that provides hospital management consulting, research and development consultancy, and hospital project consulting. It has a team of experienced professionals with expertise in various areas of healthcare, including clinical research, hospital administration, and biomedical engineering. The company aims to help hospitals and healthcare organizations with services spanning concept development, operations management, research, and regulatory compliance. It also runs online platforms for medical equipment sales and education institution listings.
Workshop de Inovação em Medical Devices
Workshop de Inovação em Medical Devices, realizado pelo EmpreenderSaúde com os professores de Stanford Robson Capasso e Ravi Pamnani.
Um workshop de um dia inteiro sobre como criar novos equipamentos médicos com a técnica (adaptada à realidade brasileira) que Stanford utiliza todos os anos para treinar médicos, engenheiros e empreendedores com o apoio de empresas como Medtronic, Covidien, Abbott, Johnson&Johnson entre outros.
Tasso, Vanessa, resume, 6-15
Vanessa Tasso has over 15 years of experience in healthcare and aerospace operations, specializing in clinical affairs, regulatory compliance, and marketing. She has a proven track record of optimizing business processes, managing clinical trials, gaining regulatory approvals, raising funds, and commercializing new medical technologies. Notable achievements include accelerating patient enrollment in a clinical trial by 500% ahead of schedule and raising $44M for an IPO. She is skilled in developing compliant documentation, navigating international trials, and creating compelling marketing materials to promote new treatments.
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Late-phase products often have complex needs, requiring clinical research informed by marketing demands. Research at this phase supports new indications, value communication, adherence strategies, long-term safety and efficacy and more. Covance has comprehensive experience in every facet of late-phase research.
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
The Ohio State University's Drug Development Institute (DDI) aims to accelerate innovative cancer research and speed cures to patients. DDI bridges the gap between Ohio State's strengths in early discovery and clinical development. DDI identifies promising molecules and technologies, partners with companies, and manages projects through various stages including target validation, lead identification, lead optimization, pre-clinical candidate development, and phase I clinical trials. DDI's team has experience in molecular biology, medicinal chemistry, clinical pharmacology, and clinical development. The document outlines DDI's services and approach, and advertises a "Drug Development Bootcamp" event focused on practical aspects of positioning research.
What Is Care?
This document provides information about CARE Worldwide Inc, a clinical research organization that conducts clinical trials. It describes CARE's global network of clinical trial sites and staff, including principal investigators, clinical research associates, clinical data managers, and other roles. It also discusses the clinical trial process, importance of training for clinical research professionals, and career opportunities in the field. The goal is to support pharmaceutical and medical device companies through quality clinical trials.
SMi Group's Pre-Filled Syringes East Coast 2016 conference
SMi Group's Prefilled Syringes East Coast 2016 conference is nearing completion. Contact us now to get involved.
Curriculum Vitaeof Dr.Mohit Saxena
Dr. Mohit N. Saxena is seeking opportunities in the pharmaceutical domain focusing on business analysis and research. He has over 8 years of experience in pharmaceutical research, pharmacovigilance operations, medical consultancy, and administration. He is competent in business research, analysis, and various IT tools. His areas of expertise include pharmaceutical management consulting, epidemiology research, forecasting, and pharmacovigilance.
About krishgen
Krishgen is an Indian biotech company established in 2003 that focuses on medical diagnostics, drug discovery research, biopharmaceuticals, and plant/food sciences. It has experienced strong growth, with revenues reaching $5 million in 2011. Krishgen provides immunoassay kits, human cell lines, glycobiology tools, and preclinical toxicology products to support research and drug development.
Amy J Opheim Resume
Amy Opheim has over 6 years of experience in pharmaceutical sales and clinical trials coordination. She currently works as a Customer Service Associate at Publicis Touchpoint Solutions, where she focuses on AstraZeneca's top drugs and increases sales through sampling and cost/coverage messaging. Previously, she held multiple roles at the Nanoscience and Nanotechnology Institute at the University of Iowa, including laboratory technician and research assistant. She has strong skills in sales, business development, clinical trials operations, and laboratory operations.
Covance Phase IV Solutions Brochure
Overcome the unique challenges of late-phase product development and generate the right data to support your products' objective. Products in late-phase development have complex needs and demands. Programs at this phase support new indications, value communication, adherence strategies, safety and efficacy and more.
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Covance has the expertise to help you overcome the unique challenges of late-phase clinical development. Find out how Covance supports new indications, value communication, adherence strategies, long-term safety and efficacy by reviewing our brochure.
About Krishgen
Krishgen is an Indian biotech company established in 2003 that focuses on developing tools for the life sciences and agri industries. It has experienced strong growth, with revenues reaching $5 million in 2011. The company provides products and services related to medical diagnostics, drug discovery research, biopharmaceuticals, and plant/food sciences.
About Krishgen
Krishgen is an Indian biotech company established in 2003 that focuses on developing tools for the life sciences and agriculture industries. It has experienced strong growth, with revenues reaching $5 million in 2011. Krishgen provides products and services related to medical diagnostics, drug discovery research, biopharmaceuticals, and plant/food sciences. It aims to enable breakthroughs in biological research and disease treatment.
VAC3 Corporate Presentation
VAC3 Clinical Services is an Indian clinical research organization established in 2010 that provides global standard clinical and medical services including medical writing, clinical research, investigator selection and training, and regulatory consultation, focusing on therapeutic areas like oncology, cardiology, and neurology. Their team of experts have decades of experience in areas like clinical research, drug development, and medical marketing. They have conducted seminars on topics like drug development processes and ethics in clinical research.
Updated capabilities overview1
Orbis Clinical is a consulting firm focused on providing regulatory affairs, quality assurance, drug safety, and risk management expertise to biopharmaceutical clients. It has over 70 employees and has experienced strong revenue growth. Orbis Clinical delivers flexible, client-driven solutions through engaged consultants and a large virtual bench of additional experts.
Navicor Capabilities
The document summarizes the services provided by The Navicor Group, a full-service healthcare marketing agency that specializes in oncology. The agency understands the oncology market, has extensive launch experience, and works with both large and small biotech and pharmaceutical clients. The agency provides a wide range of services including outsourced sales teams, advertising, digital marketing, medical education, clinical research, and consulting. Case studies demonstrate the agency's strategic approach to overcoming marketing challenges and changing perceptions within the oncology community.
Avoca Quality Consortium 2014 Summit Bio Booklet
The document summarizes the 2014 Avoca Quality Consortium Summit, which brought together quality and operations professionals from pharmaceutical, biotechnology, and clinical research organizations. The goal was to accelerate the development of best practices for proactive quality management in clinical trials. Key topics included breaking down silos, advancing technology, and building bridges to patients. Guest speakers addressed transforming clinical trial execution to improve quality. The summit provided a forum for open discussion and new ideas to emerge.
Similar to 4th & Aspen Life Sciences Consulting (20)
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
SMi Group's Pre-Filled Syringes East Coast 2016 conference
SMi Group's Pre-Filled Syringes East Coast 2016 conference
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Recently uploaded
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Transport Solution
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART INDIA MATKA KALYAN SATTA MATKA 420 INDIAN MATKA SATTA KING MATKA FIX JODI FIX FIX FIX SATTA NAMBAR MATKA INDIA SATTA BATTA
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KALYAN FIX JODI ANK LEAK FIX GAME BY DP BOSS MATKA SATTA NUMBER TODAY LUCKY NUMBER FREE TIPS ...
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
9356872877Sattamatka.satta.matka.satta matka.kalyan weekly chart.kalyan chart.kalyan jodi chart.kalyan penal chart.kalyan today.kalyan open.fix satta.fix fix fix Satta matka nambar.The Steadfast and Reliable Bull: Taurus Zodiac Sign
Explore the steadfast and reliable nature of the Taurus Zodiac Sign. Discover the personality traits, key dates, and horoscope insights that define the determined and practical Taurus, and learn how their grounded nature makes them the anchor of the zodiac.
L'indice de performance des ports à conteneurs de l'année 2023
Une évaluation comparable de la performance basée sur le temps d'escale des navires
L'objectif de l'ICPP est d'identifier les domaines d'amélioration qui peuvent en fin de compte bénéficier à toutes les parties concernées, des compagnies maritimes aux gouvernements nationaux en passant par les consommateurs. Il est conçu pour servir de point de référence aux principaux acteurs de l'économie mondiale, notamment les autorités et les opérateurs portuaires, les gouvernements nationaux, les organisations supranationales, les agences de développement, les divers intérêts maritimes et d'autres acteurs publics et privés du commerce, de la logistique et des services de la chaîne d'approvisionnement.
Le développement de l'ICPP repose sur le temps total passé par les porte-conteneurs dans les ports, de la manière expliquée dans les sections suivantes du rapport, et comme dans les itérations précédentes de l'ICPP. Cette quatrième itération utilise des données pour l'année civile complète 2023. Elle poursuit le changement introduit l'année dernière en n'incluant que les ports qui ont eu un minimum de 24 escales valides au cours de la période de 12 mois de l'étude. Le nombre de ports inclus dans l'ICPP 2023 est de 405.
Comme dans les éditions précédentes de l'ICPP, la production du classement fait appel à deux approches méthodologiques différentes : une approche administrative, ou technique, une méthodologie pragmatique reflétant les connaissances et le jugement des experts ; et une approche statistique, utilisant l'analyse factorielle (AF), ou plus précisément la factorisation matricielle. L'utilisation de ces deux approches vise à garantir que le classement des performances des ports à conteneurs reflète le plus fidèlement possible les performances réelles des ports, tout en étant statistiquement robuste.
2024.06 CPMN Cambridge - Beyond Now-Next-Later.pdf
Slides presented by Phil Hornby, Founder and Director of "for product people", at Cambridge Product Management Network, on Monday 17th June 2024.
High-Quality IPTV Monthly Subscription for $15
Experience high-quality entertainment with our IPTV monthly subscription for just $15. Access a vast array of live TV channels, movies, and on-demand shows with crystal-clear streaming. Our reliable service ensures smooth, uninterrupted viewing at an unbeatable price. Perfect for those seeking premium content without breaking the bank. Start streaming today!
https://rb.gy/f409dk
Kirill Klip GEM Royalty TNR Gold Lithium Presentation
Lithium Will Power Us For The Next 50 Years And Then Robots: Kirill Klip GEM Royalty TNR Gold Lithium Presentation
State of D2C in India: A Logistics Update
The report *State of D2C in India: A Logistics Update* talks about the evolving dynamics of the d2C landscape with a particular focus on how brands navigate the complexities of logistics. Third Party Logistics enablers emerge indispensable partners in facilitating the growth journey of D2C brands, offering cost-effective solutions tailored to their specific needs. As D2C brands continue to expand, they encounter heightened operational complexities with logistics standing out as a significant challenge. Logistics not only represents a substantial cost component for the brands but also directly influences the customer experience. Establishing efficient logistics operations while keeping costs low is therefore a crucial objective for brands. The report highlights how 3PLs are meeting the rising demands of D2C brands, supporting their expansion both online and offline, and paving the way for sustainable, scalable growth in this fast-paced market.
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
Nathalie zal delen hoe DEI en ESG een fundamentele rol kunnen spelen in je merkstrategie en je de juiste aansluiting kan creëren met je doelgroep. Door middel van voorbeelden en simpele handvatten toont ze hoe dit in jouw organisatie toegepast kan worden.
Lukas Rycek - GreenChemForCE - project structure.pptx
Projekt GreenChemForCE
Podporujeme zelený chemický průmysl ve střední Evropě
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
8328958814KALYAN MATKA | MATKA RESULT | KALYAN
8328958814KALYAN MATKA | MATKA RESULT | KALYAN KALYAN MATKA | MATKA RESULT | KALYAN MATKA TIPS | SATTA MATKA | MATKA.COM | MATKA PANA
Recently uploaded (20)
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka
The Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac Sign
L'indice de performance des ports à conteneurs de l'année 2023
L'indice de performance des ports à conteneurs de l'année 2023
2024.06 CPMN Cambridge - Beyond Now-Next-Later.pdf
2024.06 CPMN Cambridge - Beyond Now-Next-Later.pdf
Kirill Klip GEM Royalty TNR Gold Lithium Presentation
Kirill Klip GEM Royalty TNR Gold Lithium Presentation
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
Lukas Rycek - GreenChemForCE - project structure.pptx
Lukas Rycek - GreenChemForCE - project structure.pptx
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
4th & Aspen Life Sciences Consulting
- 1. 4th & Aspen Life Sciences Consulting Supercharging R&D innovation .
- 2. Our mission © 2014 4th & Aspen LLC We help companies in the discovery and development of innovative biotools & biotherapeutics. 2
- 3. Our Founders B.S., PhD Univ. of Minnesota, Minneapolis Postdoctoral research DNAX Research Institute MBA Presidio Graduate School Senior Scientist Abgenix, Inc. Senior Scientist Entelos, Inc. VP, Marketing; VP, R&D NeuroScience, Inc. Scientific Review Officer SRA International © 2014 4th & Aspen LLC 3 B.S. PhD Stanford UC-Berkeley Postdoctoral research UCSF Senior Scientist DNAX Research Institute Senior Scientist Genentech (Roche) Visiting Scientist Stanford University Chief Scientific Officer NeuroScience Inc. Chief Technical Officer R&D Systems/Techne Sirid Kellermann, President Fernando Bazan, Principal
- 4. Why work with 4th & Aspen? © 2014 4th & Aspen LLC Our key strengths: ✔ A deep understanding of how biological systems work ✔ A track record of elucidating novel target mechanisms - repeatedly breaking new ground in drug discovery (www.4thandaspen.com/our-expertise/cases) ✔ The ability to work across scientific fields and catalyze interdisciplinary collaborations that are often lacking, but critical to innovation ✔ Industry-proven decision analysis approach to guide target selection and R&D portfolio strategies ✔ Experience in biopharma market research, competitive analysis, & commercial assessment 4
- 5. We bring 3 decades of leadership in target discovery and preclinical R&D The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. © 2014 4th & Aspen LLC 5
- 6. We bring 3 decades of leadership in target discovery and preclinical R&D © 2014 4th & Aspen LLC 6 Disease-associated target discovery Protein structure/ function Cellular & in vivo validation R&D portfolio evaluation Biomarker evaluation & clinical trial optimization Market & commercial assessmentProtein signaling/ relationships
- 7. Sirid Kellermann: Strategic project & relationship management successes © 2014 4th & Aspen LLC • Strong expertise in immuno- inflammatory disorders • >20 R&D projects executed with global biopharma clients • R&D and Marketing leadership • Training in strategic decision & risk management 7
- 8. 130 publications >25,000 citations >35 patents Fernando Bazan: A track record of scientific innovation 8 © 2014 4th & Aspen LLC
- 9. Our Services Your Benefits © 2014 4th & Aspen LLC 9 Preclinical Evaluation Nuanced insights on target disease relevance; predicted effects of target perturbation Strategic recommendations for small molecule or biotherapeutic design In vitro/in vivo proof-of-concept strategy recommendations Opportunity Assessment Integrate molecular/biological and competitive/market frames Recommend program prioritization to manage risk and increase likelihood of commercial success Commercialization Support Perform in-licensing scientific diligence Guide investment/funding/spin-off decisions Support IP prosecution Facilitate collaborations with extensive industry & academic network Marketing & Writing White papers, scientific reviews, grant applications Presentations that get noticed Content marketing (blogs, etc.)
- 10. © 2014 4th & Aspen LLC Ready to supercharge your innovation engine? 10 Info[at]4thandaspen.com www.4thandaspen.com 650.996.9927